N. Rafter

发表

Do fixed-dose combination pills or unit-of-use packaging improve adherence? A systematic review.

A. Rodgers, J. Connor, N. Rafter, 2004, Bulletin of the World Health Organization.

THE NEW ZEALAND MEDICAL JOURNAL

R. Whittaker, N. Sharpe, D. Bramley, 2006 .

Integrated electronic decision support increases cardiovascular disease risk assessment four fold in routine primary care practice

Rod Jackson, Sue Wells, Natasha Rafter, 2008, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

The frequency and nature of adverse events in acute Irish hospitals: the Irish National Adverse Events Study

N. Rafter, 2016 .

An economic case for a cardiovascular polypill? A cost analysis of the Kanyini GAP trial

G. Hillis, A. Tonkin, A. Rodgers, 2014, The Medical journal of Australia.

The 'polypill', friend or foe?

A. Woodward, N. Rafter, 2005 .

Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care

R. Doughty, A. Rodgers, C. Bullen, 2014, BMJ : British Medical Journal.

‘What effect do safety culture interventions have on health care workers in hospital settings?’ A systematic review of the international literature

A. Walsh, N. Rafter, Mairéad Finn, 2022, HRB open research.

Healthcare expenditure on Indigenous and non-Indigenous Australians at high risk of cardiovascular disease

G. Hillis, A. Tonkin, A. Cass, 2017, International Journal for Equity in Health.

Will a web-based cardiovascular disease (CVD) risk assessment programme increase the assessment of CVD risk factors for Maori?

R. Whittaker, R. Jackson, D. Bramley, 2006, The New Zealand medical journal.

Recruiting equal numbers of indigenous and non-indigenous participants to a ‘polypill’ randomized trial

A. Rodgers, C. Bullen, B. Arroll, 2013, International Journal for Equity in Health.

Effectiveness of fixed dose combination medication ('polypills') compared with usual care in patients with cardiovascular disease or at high risk: A prospective, individual patient data meta-analysis of 3140 patients in six countries.

D. Prabhakaran, A. Stanton, D. Grobbee, 2016, International journal of cardiology.

Prospective meta-analysis of trials comparing fixed dose combination based care with usual care in individuals at high cardiovascular risk: the SPACE Collaboration.

D. Prabhakaran, A. Stanton, D. Grobbee, 2013, International journal of cardiology.

A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk

Samantha J. Togni, C. Reid, G. Hillis, 2015, European journal of preventive cardiology.

Effect of after action review on safety culture and second victim experience and its implementation in an Irish hospital: A mixed methods study protocol

A. Walsh, N. Rafter, C. Stuart, 2021, PloS one.

An International Randomised Placebo-Controlled Trial of a Four-Component Combination Pill (“Polypill”) in People with Raised Cardiovascular Risk

D. Grobbee, A. Rodgers, M. Bots, 2011, PloS one.

IMProving Adherence using Combination Therapy (IMPACT): design and protocol of a randomised controlled trial in primary care.

R. Doughty, A. Rodgers, B. Arroll, 2011, Contemporary clinical trials.

Gaps in primary care documentation of cardiovascular risk factors.

R. Whittaker, R. Jackson, D. Bramley, 2008, The New Zealand medical journal.

National and Institutional Trends in Adverse Events Over Time: A Systematic Review and Meta-analysis of Longitudinal Retrospective Patient Record Review Studies

R. Conroy, A. Hickey, N. Rafter, 2020, Journal of patient safety.

Adverse events in healthcare: learning from mistakes.

R. Conroy, A. Hickey, N. Rafter, 2015, QJM : monthly journal of the Association of Physicians.

Reaching cardiovascular prevention guideline targets with a polypill-based approach: a meta-analysis of randomised clinical trials

G. Hillis, A. Stanton, D. Grobbee, 2018, Heart.

Using run charts for cardiovascular disease risk assessments in general practice.

Chris Bullen, Susan Wells, Ying Huang, 2016, Journal of primary health care.

The Irish National Adverse Events Study (INAES): the frequency and nature of adverse events in Irish hospitals—a retrospective record review study

R. Conroy, A. Hickey, N. Rafter, 2016, BMJ Quality & Safety.

Do polypills lead to neglect of lifestyle risk factors? Findings from an individual participant data meta-analysis among 3140 patients at high risk of cardiovascular disease

G. Hillis, D. Grobbee, A. Tonkin, 2016, European journal of preventive cardiology.

The impact of a point-of-care testing device on CVD risk assessment completion in New Zealand primary-care practice: A cluster randomised controlled trial and qualitative investigation

Chris Bullen, Yannan Jiang, Sue Wells, 2017, PloS one.

The Irish National Adverse Event Study-2 (INAES-2): longitudinal trends in adverse event rates in the Irish healthcare system

R. Conroy, A. Hickey, N. Rafter, 2021, BMJ Quality & Safety.

The Effect of a Cardiovascular Polypill Strategy on Pill Burden.

G. Hillis, A. Tonkin, A. Rodgers, 2015, Cardiovascular therapeutics.

Cardiovascular medications in primary care: treatment gaps and targeting by absolute risk.

A. Rodgers, V. Parag, R. Jackson, 2005, The New Zealand medical journal.

Polypill-based therapy likely to reduce ethnic inequities in use of cardiovascular preventive medications: Findings from a pragmatic randomised controlled trial

C. Bullen, V. Parag, B. Arroll, 2016, European Journal of Preventive Cardiology.

IMProving Adherence using Combination Therapy (IMPACT): design and protocol of a randomised controlled trial in primary care.

R. Doughty, A. Rodgers, B. Arroll, 2011, Contemporary clinical trials.

Cardiovascular treatment gaps: closing, but slowly.

A. Rodgers, V. Parag, S. Dovey, 2009, The New Zealand medical journal.